NASDAQ: PRE - Prenetics Global Limited

Lønnsomhet i seks måneder: +83.45%
Sektor: Healthcare

Kampanjeplan Prenetics Global Limited


Om selskapet

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use.

Flere detaljer
The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Выручка 0.0092
EBITDA -0.0185
Число акций ао 0.01125 млрд
P/S 4.92
P/BV -3.38
EV/EBITDA 0.5737
Цена ао 3.56
ISIN KYG722451062
Сайт https://www.prenetics.com
Валюта usd
IPO date 2022-05-18
Sector Financials
Industry Insurance
Валюта отчета usd
Prisendring per dag: +1.72% (5.23)
Prisendring per uke: +37.11% (3.88)
Prisendring per måned: +18.22% (4.5)
Prisendring over 3 måneder: -6.85% (5.711)
Prisendring over seks måneder: +83.45% (2.9)
Prisendring per år: +1 084.86% (0.449)
Prisendring over 3 år: -46% (9.8522)
Prisendring siden begynnelsen av året: +13.19% (4.7)

Undervurdering

Navn Betydning Karakter
P/S 2.83 6
P/BV 0.2927 10
P/E 0 0
EV/EBITDA -0.4065 0
Total: 5.75

Effektivitet

Navn Betydning Karakter
ROA, % -24.68 0
ROE, % -30.4 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 1.35

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.053 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 136.33 10
Lønnsomhet Ebitda, % 141.73 10
Lønnsomhet EPS, % 2964.52 10
Total: 10

ETF Dele, % Lønnsomhet for året, % Utbytte, %
Vanguard Intermediate-Term Bond ETF 0.01 3.1728813559322 3.45
Schwab U.S. Aggregate Bond ETF 0 2.9117581684819 3.65
Vanguard Intermediate-Term Corporate Bond ETF 0.02 4.6240553349558 4.17



Veileder Stillingstittel Betaling Fødselsår
Mr. Hoi Chun Lo Chief Financial Officer N/A 1985 (39 år)
Dr. Yung Ho Wong DPHIL Chief Technology Officer N/A 1982 (42 år)
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President of People & Operations N/A
Dr. Senthil Sundaram M.D. Chief Clinical Officer N/A 1974 (50 år)
Mr. Joel Neoh Chief Consumer Officer & CEO for CircleDNA N/A 1984 (40 år)
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO N/A 1979 (45 år)
Dr. Chi Hung Tzang Ph.D. Co-Founder & Chief Scientific Officer N/A 1974 (50 år)
Mr. Walt Ling Chief Executive Officer of ACT Genomics N/A

Adresse: Hong Kong, Quarry Bay, Unit 701-706. K11 Atelier King’s Road - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.prenetics.com